Lipid replacement and antioxidant nutritional therapy for restoring mitochondrial function and reducing fatigue in chronic fatigue syndrome and other fatiguing illnesses

Journal of Chronic Fatigue Syndrome

Volumn 13, Issue 1, 2006, Pages 57-68

  Nicolson, Garth L ^a   Ellithorpe, Rita ^a  

^a INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

Antioxidants; Chronic fatigue syndrome; Dietary supplement; Fatigue; Lipids; Mitochondria; Therapy

Indexed keywords

ANTIOXIDANT; LIPID; MEMBRANE LIPID; REACTIVE OXYGEN METABOLITE;

AGING; CHRONIC FATIGUE SYNDROME; DIET THERAPY; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; FATIGUE; HUMAN; LIPID PEROXIDATION; LIPID REPLACEMENT THERAPY; MITOCHONDRIAL MEMBRANE; OUTCOME ASSESSMENT; OXIDATION; OXIDATIVE STRESS; PIPER FATIGUE SCALE; RATING SCALE; RESPIRATORY CHAIN; REVIEW; TIME;

EID: 33748563980     PISSN: 10573321     EISSN: 15470660     Source Type: Journal    
DOI: 10.1300/J092v13n01_06     Document Type: Review

References (52)

1. Huang H, Manton KG. The role of oxidative damage in mitochondria during aging: a review. Front Biosci 2004; 9:1100-1117.
2. 2+-induced permeability transition of mitochondria. Free Radical Res 2004; 38(1):27-35.
3. Nicolson GL, Poste G, Ji T. Dynamic aspects of cell membrane organization. Cell Surface Rev 1977; 3:1-73.
4. Subczynski WK, Wisniewska A. Physical properties of lipid bilayer membranes: relevance to membrane biological functions. Acta Biochim Pol 2000; 47:613-625.
5. Logan AC, Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev 2001; 6(5):450-459.
6. Manuel y Keenoy B, Moorkens G, Vertommen J, De leeuw I. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci 2001; 68:2037-2049.
7. Nicolson GL. Lipid replacement as an adjunct to therapy for chronic fatigue, anti-aging and restoration of mitochondrial function. J Am Nutraceut Assoc 2003; 6(3):22-28.
8. Harris WS. n-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 1996; 31:243-252.
9. Connor WE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 2000; 71:S171-S178.
10. Butcher G, Hengstler HC, Schindler P, Meier C. n-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002; 112:298-304.
11. Belluzzi A. n-3 fatty acids for the treatment of inflammatory bowel diseases. Proc Nutr Soc 2002; 61:391-393.
12. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002; 61:345-358.
13. Grimble RF. Nutritional modulation of immune function. Proc Nutr Soc 2001; 60:389-397.
14. Hajri T, Abumrad NA. Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr 2002; 22:383-415.
15. Hamilton JA. Fatty acid transport: difficult or easy? J Lipid Res 1998; 39(3):467-481.
16. Fellmann P, Herve P, Pomorski T, Muller P, et al. Transmembrane movement of diether phospholipids in human erythrocytes and human fibroblasts. Biochem 2000; 39:4994-5003.
17. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003; 422:37-44.
18. Mansbach CM, Dowell R. Effect of increasing lipid loads on the ability of the endoplasmic reticulum to transport lipid to the Golgi. J Lipid Res 2000; 41:605-612.
19. Kroenke K, Wood DR, Mangelsdorff AD, et al. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA 1988; 260:929-934.
20. Morrison JD. Fatigue as a presenting complaint in family practice. J Family Pract 1980; 10:795-801.
21. Piper BF, Dribble SL, Dodd MJ, et al. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nursing Forum 1998; 25:667-684.
22. McDonald E, David AS, Pelosi AJ, Mann AH. Chronic fatigue in primary care attendees. Psychol Med 1993; 23:987-998.
23. Piper BF, Linsey AM, Dodd MJ. Fatigue mechanism in cancer. Oncol Nursing Forum 1987; 14:17-23.
24. Richter C, Par JW, Ames B. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Nat Acad Sci USA 1998; 85:6465-6467.
25. Wei YH, Lee HC. Oxidative stress, mitochondrial DNA mutation and impairment of antioxidant enzymes in aging. Exp Biol Med 2002; 227:671-682.
26. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956; 2:298-300.
27. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001; 18:685-716.
28. Tan, NSS, Vinckenbosch NS, Liu N, Yasmin P, Desvergne R, et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 2002; 22:5114-51127.
29. Chen D, Cao G, Hastings T, et al. Age-dependent decline of DNA repair activity for oxidative lesions in rat brain mitochondria. J Neurochem 2002; 81:1273-1284.
30. Xu D, Finkel T. A role for mitochondria as potential regulators of cellular life span. Biochem Biophysics Res Commun 2002; 294:245-248.
31. Richards RS, Roberts TK, McGregor NR, et al. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep 2000; 5:35-41.
32. Felle S, Mecocci P, Fano G, et al. Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radical Biol Med 2000; 29:1252-1259.
33. Pall ML. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypotheses 2000; 54:115-125.
34. Castro L, Rodriguez M, Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 1994; 269:29409-29415.
35. Radi R, Rodriguez M, Castro L, Telleri R. Inhibition of mitochondrial electronic transport by peroxynitrite. Arch Biochem Biophys 1994; 308:89-95.
36. Manuel Y, Keenoy B, Moorkens G, Vertommen J, et al. Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium. J Am Coll Nutr 2000; 19:374-382.
37. De AK, Darad R. Age-associated changes in antioxidants and antioxidative enzymes in rats. Mech Ageing Dev 1991; 59:123-128.
38. Ames BM. Micronutrients prevent cancer and delay aging. Toxicol Lett 1998; 102:1035-1038.
39. Sharman EH, Bondy SC. Effects of age and dietary antioxidants on cerebral electron transport chain activity. Neurobiol Aging 2001; 22:629-634.
40. Sugiyama S, Yamada K, Ozawa T. Preservation of mitochondrial respiratory function by coenzyme Q10 in aged rat skeletal muscle. Biochem Mol Biol Int 1995; 37:1111-1120.
41. Lin M, Simon D, Ahn C, Lauren K, Beal MF. High aggregrate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Human Mol Genet 2002; 11:133-145.
42. Matthews RT, Yang L, Browne S, et al. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 1998; 95:8892-8897.
43. Miquel J. Can antioxidant diet supplementation protect against age-related mitochondrial damage? Ann NY Acad Sci 2002; 959:317-347.
44. De AK, Darad R. Age-associated changes in antioxidants and antioxidative enzymes in rats. Mech Ageing Dev 1991; 59:123-128.
45. Ellithorpe RR, Settineri R, Nicolson GL. Pilot Study: reduction of fatigue by use of a dietary supplement containing glycophospholipids. J Am Nutraceut Assoc 2003; 6(1):23-28.
46. Agadjanyan M, Vasilevko V, Ghochikyan A, Berns P, Kesslak P, Settineri R, Nicolson GL. Nutritional supplement (NTFactor) restores mitochondrial function and reduces moderately severe fatigue in aged subjects. J Chronic Fatigue Syndr 2003; 11(3):23-26.
47. Seidman M, Khan MJ, Tang WX, Quirk WS. Influence of lecithin on mitochondrial DNA and age-related hearing loss. Otolaryngol Head Neck Surg 2002; 127:138-144.
48. Kim MJ, Cooper DD, Hayes SF, Spangrude GJ. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 1998; 91:4106-4117.
49. Colodny L, Lynch K, Farber C, Papish S, et al. Results of a study to evaluate the use of Propax to reduce adverse effects of chemotherapy. J Am Nutraceut Assoc 2000; 2:17-25.
50. Paradies G, Petrosillo G, Pistolese M, Ruggiero F. Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 2002; 286:135-141.
51. Kowald A. The mitochondrial theory of aging: Do damaged mitochondria accumulate by delayed degradation? Exp Gerontol 1999; 34:605-612.
52. Johns DR. 1995. Seminars in medicine of Beth Israel Hospital, Boston: Mitochondrial DNA and Disease. New Engl J Med 1995; 333:638-44.